Navigation Links
LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment
Date:10/1/2013

results of and projected timing of clinical trials of LX4211, and the potential therapeutic and commercial potential of LX4211.  The press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2012, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
3. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
4. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
5. LX4211 Phase 2b Results Presented At American Heart Association Annual Conference
6. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
7. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
8. Greenville Hospital System Achieves Dramatic Improvement in Hand Hygiene Compliance Rates Using New Technology from DebMed®
9. Acuo Technologies Grows European Business and Achieves Successful Connectathon Results in Bern, Switzerland
10. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
11. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Harwood Feffer LLP ( www.hfesq.com ... directors of PDL BioPharma, Inc. ("PDL" or the "Company") ... has breached its fiduciary duties to shareholders or violated ... 2014, the Company disclosed: "On September 11, 2014, [PDL] ... Ernst & Young LLP ("EY"), that it was resigning ...
(Date:9/19/2014)... Pa. , Sept. 19, 2014  Today ... two new variable angle plating systems featuring its ... surgeons can adapt screw trajectory to match patient ... specific fragments of bone. The systems are being ... & Ankle Society (AOFAS) and the International Federation ...
(Date:9/19/2014)... , Sept. 19, 2014 The Parenteral Drug ... harmonize global post-approval changes protocols. The ... the topic expressed by industry participants and regulatory authority ... this month in Washington, DC . ... on hand for the workshop. Attendees indicated openness to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2
... Diagnostics, an FDA licensed and ISO certified biomedical ... CulGenex™, a new brand of culture media, biological ... purification kits, and transfection reagents for molecular biology ... Crowe (molecular biologist from the University of Pittsburgh) ...
... Kan., Sept. 16 ScriptPro has been awarded a ... National Institutes of Health (NIH) in ... and drug information systems will be implemented in the ... control and identification of drugs and enhance the safety ...
Cached Medicine Technology:CulGenex™ by Hardy Diagnostics Assists Medical Researchers! 2National Institutes of Health Chooses ScriptPro for Pharmacy Automation 2
(Date:9/20/2014)... the popular online supplier of wedding dresses and special ... collection of cocktail gowns. This afternoon, the company announced ... outfits; it intends to expand its online market in ... cocktail dresses in the company’s online store. ... experience in the industry of women’s special occasion dresses. ...
(Date:9/20/2014)... Recently, UWDress.com, an innovative company that ... occasion outfits, has launched a special offer for its ... are popular among worldwide clients. Now, all the company’s ... dresses on its website. , Additionally, the firm ... the world. Great custom made items can be ordered ...
(Date:9/20/2014)... September 20, 2014 Final Cut Pro ... the release of the Information theme for FCPX filmmakers. , ... to describe the Information theme,” says Christina Austin, CEO of ... look so professional.” , Information features easy to use controls ... of the environment. Change the background color, color of each ...
(Date:9/20/2014)... September 20, 2014 The children of ... balanced and active play they need. An empty lot ... - Lakeview Campus was transformed into a kid-designed playspace ... 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), ... KaBOOM! believes a playground is more than a playground. ...
(Date:9/19/2014)... 19, 2014 Unbound , an international ... in regions of the Philippines being affected by both a ... 1,060 families evacuated to the nearest public schools while others ... rain and gusty winds to portions of the northern Philippines. ... Some homes filled with more than 10 feet of water. ...
Breaking Medicine News(10 mins):Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2
... Gist, D.D.S., who practices general dentistry in Flint, Mich., was ... during a meeting of the ADA House of Delegates ... ADA presidency in October 2010 and will lead the more ... Dr. Gist will be the ADA,s first African-American president. , ...
... , - Significant variation exists in the quality of ... disease in U.S. hospitals. , - Hospitals receiving performance ... Guidelines (GWTG) quality improvement program appear to have better ... DALLAS, Oct. 6 Hospitals receiving performance awards from ...
... Winner Medical Group Inc. (OTC Bulletin Board: WWIN; "Winner ... largest exporter by volume in the medical dressing industry ... to list its common stock on NYSE Amex. , ... on Thursday, October 8, 2009, until which time its ...
... prevention or delay of full-blown disease seen in treated ... Among patients who show early signs of multiple sclerosis, ... halve the risk that they will develop full-blown disease, ... who are diagnosed with multiple sclerosis first show signs ...
... a leading brand in the weight management industry, launched Metabolife ... about positive, incremental changes to their lives and the lives ... with the launch of www.joinlessismore.com . , ... changes that delivers lasting results and weight loss is just ...
... West Bloomfield Hospital is embarking on a research study for ... , The clinical trial will test whether gene transfer ... who have lost responsiveness to drug therapy. , ... Parkinson,s disease patient population that has had a long-standing need ...
Cached Medicine News:Health News:Michigan Dentist Chosen President-Elect of the American Dental Association 2Health News:American Heart Association Quality News: Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 2Health News:American Heart Association Quality News: Commitment to Quality Results in Lower Mortality Rates for Heart Attack and Heart Failure Patients 3Health News:Winner Medical to Begin Trading on NYSE Amex on October 8, 2009 2Health News:Winner Medical to Begin Trading on NYSE Amex on October 8, 2009 3Health News:Early Drug Treatment May Cut Multiple Sclerosis Risk 2Health News:Communities Nationwide Learn 'Less Is More' from Metabolife(R) Through 1,000 In-Home Parties and An Interactive Site www.joinlessismore.com 2Health News:Communities Nationwide Learn 'Less Is More' from Metabolife(R) Through 1,000 In-Home Parties and An Interactive Site www.joinlessismore.com 3Health News:Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinson's Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: